A research team at the University of Würzburg has deciphered another aspect of poxviral gene activation. They have revealed a ...
Digi Communications N.V. announces the publication of the 2024 Annual Financial Report and convocation of the Company’s general shareholders meeting for June 18, 2025, for the approval of, among ...
A joint research by Chinese scientists has recently found that the oral nucleoside drug VV116, approved for the treatment of COVID-19, shows significant antiviral activity against Nipah virus, ...
The Department of Science and Technology (DOST) is conducting a series of public consultations to draft the implementing rules and regulations (IRR) of Republic Act 12290 or the Virology and Vaccine ...
DOST officials, industry experts and stakeholders from government, academe, research institutions and the private sector pose for a photo during the Visayas leg of the public consultation on the ...
Fans of Stephen King’s IT as well as the two film adaptation installments will be excited to return to the world of Pennywise the clown in prequel series IT: Welcome to Derry. Developed for television ...
“It: Welcome to Derry” is about to open up a lot of lore about Pennywise and why it haunts the small town it does. The new HBO series explores the earlier days of the cosmic monster that the Losers ...
Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in ...
Gilead Sciences has bolted another asset onto the virology engine that powers the company, paying (PDF) Health Hope Pharma $10 million upfront for global rights to a candidate in a limited set of ...
The Trump Administration Misses Key Deadlines for Imposing Restrictions on Gain-of-Function Research
Biosafety hawks were initially optimistic that the incoming second Trump administration would at last place binding constraints on so-called "dangerous gain-of-function" research, in which pathogens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results